"MS (Multiple Sclerosis) Clinic and General Neurology Department and Research office. Pre covid 3 neurologists on site almost daily and 3 visiting doctors for MS patients. 2 nurses available virtually daily as well. Currently we are offering phone calls (or virtual video calls if necessary). The wait list for NEW patients is currently 4 weeks once intake forms are filled out. You may email us at msclinic@fraserhealth.ca for forms and information once a referral has been sent by the referring doctor to us."

During the past decade, Fraser Health Authority - Fraser Health Multiple Sclerosis conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fraser Health Authority - Fraser Health Multiple Sclerosis" #1 collaborator was "Multiple Sclerosis Society of Canada" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fraser Health Authority - Fraser Health Multiple Sclerosis" are "Clinically Isolated Syndromes" (1 trials), "Early Single Relapse of Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Primary Progressive Multiple Sclerosis" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Fraser Health Authority - Fraser Health Multiple Sclerosis" in a lesser frequency.

Most popular intervention types in "Fraser Health Authority - Fraser Health Multiple Sclerosis" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Placebo" (2 trials), "ATA188" (1 trials), "Fenebrutinib" (1 trials) and "Minocycline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fraser Health Authority - Fraser Health Multiple Sclerosis" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fraser Health Authority - Fraser Health Multiple Sclerosis". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fraser Health Authority - Fraser Health Multiple Sclerosis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fraser Health Authority - Fraser Health Multiple Sclerosis, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".